BitMart suffered a second hack on November 2, 2026, losing about $391,000 mainly through Ethereum layer-2 networks. This loss is small compared to the $319.5 million shortfall from a 2021 hack but highlights ongoing security weaknesses during BitMart's restructuring. The exchange is understaffed and preparing a revised creditor repayment plan due in November, with court approval expected by early 2027. Users should document their balances carefully as they now hold claims rather than free balances, and beware of phishing scams exploiting the situation.
The BitMart hack involved a loss of about $391,000, a notable figure amid ongoing security challenges. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Nov 04, 2026 23:32 WIB: out of 50 major cryptocurrencies, 47 rose and 2 fell. Notable movers include LINK at Rp210.973 with a 1-day change of +4.80% and Pluang order activity of 27% Sell / 73% Buy, ADA at Rp3.605 with +4.52% change and 18% Sell / 82% Buy activity, and AVAX at Rp162.234 with +4.52% change and 38% Sell / 62% Buy activity.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
